Patent · US Active

Compositions and methods for treating non-age-associated hearing impairment in a human subject

US11781145B2 · kind B2 · utility

5Cited by

33References

29Claims

0Family size

Assignee

Akouos, Inc. · US

Inventors

Emmanuel John Simons · Brookline, US
Ellen Reisinger · Dußlingen, DE
Sebastian Kügler · Göttingen, DE
Hanan Al-Moyed · Göttingen, DE

Key dates

Filing date	Sep 2, 2022
Grant date	Oct 10, 2023
Priority date	—
Expiry date	Sep 2, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y301/03001
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are compositions that include at least two different nucleic acid vectors, where each of the at least two different vectors includes a coding sequence that encodes a different portion of an otoferlin protein, and the use of these compositions to treat hearing loss in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.